My child needs glasses for distance vision…
What causes this?
Near-sightedness, also called myopia, occurs when patients can see well up close, but have blurred distance vision.
Near-sightedness is caused from the eye itself growing longer over time, stretching out the retina and neurological tissue, which results in progressive vision loss and prescription changes.
The changes in eye shape can occur due to genetics, but also correlate with “near work.” With the advent of digital devices, our children now spend hours more per day on screens than most of us did at a similar age. We know conclusively that children who spend more time indoors are at risk for becoming myopic.
Why should I try to prevent near-sightedness?
Because of the stretching that occurs with retinal tissue, it makes sense that these patients are at significantly higher risk of retinal detachments, glaucoma, and a host of other ocular diseases later in life, in addition to overall worsening vision.
What can I do to help preserve my child’s vision?
Until recently, most children who are near-sighted were likely to have their vision progressively worsen over time. They would continue to have prescription changes in almost all cases.
However, we now seek ways to slow down the changes to eye shape, which is called “Myopia Control.” Myopia Control has been a mainstay of our practice for nearly a decade now, and Dr. Neukirch is one of the leading Myopia Control providers in the Chicagoland area.
To date, we have successfully utilized technology called Orthokeratology, and also Atropine therapy with hundreds of our young patients.
Orthokeratology is a fantastic method that involves wearing contact lenses overnight to mold and reshape the cornea. While this therapy is very effective, many children are not great candidates and there is a learning curve for both children and their patients. Atropine therapy requires off-label use (i.e. not FDA approved) and must be obtained from a specialty compounding pharmacy.
Now, there is an additional option: MiSight.
MiSight is a 1-day disposable, soft contact lens that fits and feels like a usual contact lens. It not only corrects distance vision, like a typical contact lens or glasses, but has the added benefit of being clinically proven (and FDA approved) to slow the progression of myopia.
In fact, compared to a leading conventional 1-day lens made from the same material, children wearing MiSight were 10 times more likely to show no meaningful myopia progression. We have already fit dozens of children in this lens and are pleased to report high patient satisfaction. We believe it will quickly become the lens of choice for our myopic, school-aged patients.
Is my child a candidate for MiSight?
If your child is 8 years or older and requires glasses, please give us a call to schedule their annual eye exam or CLICK HERE to make an appointment. If they are a current patient and not yet due, let us know you are interested in finding out more about myopia control and one our doctors can determine if they are a candidate without having to come in.
To learn more about MiSight & Brilliant Futures program, or to read the studies referenced yourself, please click on the links below:
References, Clinical Studies, and continued reading:
MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
What You Should Know if Your Child is Nearsighted (Infographic). Retrieved October 29, 2019 from: https://www.allaboutvision.com/parents/myopia-facts-infographic.htm
Macular Society. Myopia, Pathological Myopia and Myopic Macular Degeneration. Retrieved October 29, 2019 from: https://www.macularsociety.org/sites/default/files/resource/Macular%20Society%20Factsheet%20-%20Myopic%20Macular%20Degeneration%202017%20-%20ACCESS.pdf
Flitcroft, D. (2012). The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research. 31(6): 622-660.
Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Global Health.013;1:e339–e349.
The Impact of Myopia and High Myopia. Report of the Joint World Health Organization-Brien Holden Vision Institute Global Scientific Meeting on Myopia. University of New South Wales, Sydney, Australia. 16-18 March 2015.
Chamberlain P, Logan N, Jones D, Gonzalez-Meijome J, Saw S-M, Young G. Clinical evaluation of a dual-focus myopia control 1 day soft contact lens. 3-year results (2016 American Academy of Optometry Annual Meeting) and 5-year results (2019 BCLA Clinical Conference & Exhibition).
Holden et al, – Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016. 123(5):1036-1042
Theophanous C, Modjtahedi BS, Batech M, Marlin DS, Luong TQ, Fong DS. Myopia prevalence and risk factors in children. Clin Ophthalmol. 2018;12:1581–1587. Published 2018 Aug 29. doi:10.2147/OPTH.S164641
Xu L, et al. High myopia and Glaucoma susceptibility for the Beijing Eye Study. Ophthalmology. 2007;114(2):216-20. 2. Bourne RR, et al. Causes of vision loss worldwide, 1990-2010: a systemic analysis. Lancet Glob Health. 2013;1(6):e339-49. 3. CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey 6/27/19 to 7/18/19 of n=313 ECPs (who see at least 1/month myopic child, age 8-15) in U.S. 4. Yu L, et al. Epidemiology, genetics and treatments for myopia. Int J Ophthalmol. 2011;4(6):658-69.